Cannabis products, excluding Jazz Pharmaceuticals Plc’s epilepsy drug Epidiolex, are illegal at the federal level in the United States, although some states allow their use.
https://www.pharmalive.com/wp-content/uploads/2023/01/marijuana-cookies.jpg500616Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-01-26 13:45:562023-01-27 09:11:06U.S. FDA calls for new regulatory framework for use of cannabis compound CBD
